Effect of Hypoxia on Endothelial Nitric Oxide Synthase, NO Production, Intracellular Survival Signaling (p-ERK1/2 and p-AKT) and Apoptosis in Human Term Trophoblast

American Journal of Reproductive Immunology

Volumn 65, Issue 4, 2011, Pages 407-414

  Park, Mi Hye ^a,b   Galan, Henry L ^a   Arroyo, Juan A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Ewha Womans University   (South Korea)

Author keywords

Apoptosis; ENOS; Hypoxia; Signal transduction; Trophoblast

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; OXYGEN; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; INTRACELLULAR SIGNALING; INTRAUTERINE GROWTH RETARDATION; NICK END LABELING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TROPHOBLAST; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IN SITU NICK-END LABELING; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TROPHOBLASTS;

EID: 79952295070     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2010.00886.x     Document Type: Article

References (31)

1. Pollack RN, Divon MY: Intrauterine growth retardation: definition, classification, and etiology. Clin Obstet Gynecol 1992; 35:99-107.
2. Barker DJ: The intrauterine origins of cardiovascular disease. Acta Paediatr Suppl 1993; 82(Suppl. 391):93-99.
3. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS: Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341:938-941.
4. Viero S, Chaddha V, Alkazaleh F, Simchen MJ, Malik A, Kelly E, Windrim R, Kingdom JC: Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 2004; 25:735-741.
5. Arroyo JA, Anthony RV, Galan HL: Decreased placental X-linked inhibitor of apoptosis protein in an ovine model of intrauterine growth restriction. Am J Obstet Gynecol 2008; 199:80-88.
6. Arroyo JA, Anthony RV, Parker TA, Galan HL: Differential expression of placental and vascular endothelial nitric oxide synthase in an ovine model of fetal growth restriction. Am J Obstet Gynecol 2006; 195:771-777.
7. Barrio E, Calvo MT, Romo A, Alvarez R, Gutierrez JI, Nava J, Ferrendez Longas A: Intrauterine growth retardation: study of placental apoptosis. J Pediatr Endocrinol Metab 2004; 17(Suppl. 3):451-456.
8. Galan HL, Regnault TR, Le Cras TD, Tyson RW, Anthony RV, Wilkening RB, Abman SH: Cotyledon and binucleate cell nitric oxide synthase expression in an ovine model of fetal growth restriction. J Appl Physiol 2001; 90:2420-2426.
9. Hagen AS, Orbus RJ, Wilkening RB, Regnault TR, Anthony RV: Placental expression of angiopoietin-1, angiopoietin-2 and tie-2 during placental development in an ovine model of placental insufficiency-fetal growth restriction. Pediatr Res 2005; 58:1228-1232.
10. Kiss H, Schneeberger C, Tschugguel W, Lass H, Huber JC, Husslein P, Knöfler M: Expression of endothelial (type III) nitric oxide synthase in cytotrophoblastic cell lines: regulation by hypoxia and inflammatory cytokines. Placenta 1998; 19:603-611.
11. Myatt L, Brewer A, Brockman DE: The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991; 164:687-692.
12. Schiessl B, Mylonas I, Hantschmann P, Kuhn C, Schulze S, Kunze S, Friese K, Jeschke U: Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, preeclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem 2005; 53:1441-1449.
13. Smith SC, Baker PN, Symonds EM: Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997; 177:1395-1401.
14. Lowenstein CJ, Dinerman JL, Snyder SH: Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120:227-237.
15. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
16. Zarlingo TJ, Eis AL, Brockman DE, Kossenjans W, Myatt L: Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta 1997; 18:511-520.
17. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE: AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999; 443:285-289.
18. Fleming I, Busse R: Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003; 284:R1-R12.
19. Fulton D, Gratton JP, Sessa WC: Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 2001; 299:818-824.
20. Stuehr DJ: Mammalian nitric oxide synthases. Biochim Biophys Acta 1999; 1411:217-230.
21. Huppertz B, Hunt JS: Trophoblast apoptosis and placental development - a workshop report. Placenta 2000; 21(Suppl. A):S74-S76.
22. Levy R, Nelson DM: To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 2000; 21:1-13.
23. Chen EY, Mazure NM, Cooper JA, Giaccia AJ: Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res 2001; 61:2429-2433.
24. Jiang Z, Zhang Y, Chen X, Lam PY, Yang H, Xu Q, Yu AC: Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem Biophys Res Commun 2002; 294:726-733.
25. Arroyo J, Torry RJ, Torry DS: Deferential regulation of placenta growth factor (PlGF)-mediated signal transduction in human primary term trophoblast and endothelial cells. Placenta 2004; 25:379-386.
26. Chen JX, Meyrick B: Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab Invest 2004; 84:182-190.
27. Levy R, Smith SD, Chandler K, Sadovsky Y, Nelson DM: Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol 2000; 278:C982-C988.
28. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA: Placental apoptosis in preeclampsia. Obstet Gynecol 2000; 96:271-276.
29. Cho DH, Lee HJ, Kim HJ, Hong SH, Pyo JO, Cho C, Jung YK: Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2. Oncogene 2007; 26:2809-2814.
30. Perkins J, St John J, Ahmed A: Modulation of trophoblast cell death by oxygen and EGF. Mol Med 2002; 8:847-856.
31. Kilani RT, Mackova M, Davidge ST, Guilbert LJ: Effect of oxygen levels in villous trophoblast apoptosis. Placenta 2003; 24:826-834.